U.S. Physical Therapy, Inc. $USPH Holdings Lifted by American Century Companies Inc.

American Century Companies Inc. increased its holdings in U.S. Physical Therapy, Inc. (NYSE:USPH) by 45.9% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,204 shares of the company’s stock after acquiring an additional 4,153 shares during the period. American Century Companies Inc. owned about 0.09% of U.S. Physical Therapy worth $955,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. GW&K Investment Management LLC increased its holdings in shares of U.S. Physical Therapy by 8.9% in the 1st quarter. GW&K Investment Management LLC now owns 344,390 shares of the company’s stock valued at $24,920,000 after purchasing an additional 28,203 shares during the period. Envestnet Asset Management Inc. grew its position in U.S. Physical Therapy by 5.6% during the first quarter. Envestnet Asset Management Inc. now owns 316,489 shares of the company’s stock valued at $22,901,000 after purchasing an additional 16,698 shares in the last quarter. Northern Trust Corp increased its stake in U.S. Physical Therapy by 13.9% in the 4th quarter. Northern Trust Corp now owns 261,825 shares of the company’s stock valued at $23,226,000 after buying an additional 32,024 shares during the period. Point72 Asset Management L.P. purchased a new stake in U.S. Physical Therapy in the 4th quarter worth approximately $18,886,000. Finally, Silvercrest Asset Management Group LLC boosted its stake in shares of U.S. Physical Therapy by 24.8% during the 4th quarter. Silvercrest Asset Management Group LLC now owns 189,115 shares of the company’s stock valued at $16,776,000 after buying an additional 37,523 shares during the period.

Analysts Set New Price Targets

A number of research firms have recently weighed in on USPH. Zacks Research raised shares of U.S. Physical Therapy to a “hold” rating in a research note on Friday, August 8th. Wall Street Zen upgraded U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Thursday, May 8th. Finally, Barrington Research raised their price target on U.S. Physical Therapy from $98.00 to $103.00 and gave the stock an “outperform” rating in a research note on Friday, August 8th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $110.25.

Insider Buying and Selling

In other news, CFO Carey P. Hendrickson sold 698 shares of the company’s stock in a transaction that occurred on Monday, August 25th. The stock was sold at an average price of $86.11, for a total transaction of $60,104.78. Following the completion of the transaction, the chief financial officer directly owned 27,808 shares in the company, valued at $2,394,546.88. The trade was a 2.45% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Graham D. Reeve sold 1,792 shares of the stock in a transaction that occurred on Monday, August 11th. The shares were sold at an average price of $86.57, for a total value of $155,133.44. Following the completion of the sale, the chief operating officer directly owned 22,246 shares of the company’s stock, valued at $1,925,836.22. This represents a 7.45% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 3,653 shares of company stock valued at $311,274. Insiders own 2.00% of the company’s stock.

U.S. Physical Therapy Price Performance

Shares of U.S. Physical Therapy stock opened at $83.61 on Thursday. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 0.30. The firm has a fifty day simple moving average of $79.53 and a 200-day simple moving average of $76.73. The stock has a market capitalization of $1.27 billion, a price-to-earnings ratio of 36.51, a PEG ratio of 4.15 and a beta of 1.47. U.S. Physical Therapy, Inc. has a 1-year low of $62.77 and a 1-year high of $101.19.

U.S. Physical Therapy (NYSE:USPH) last posted its earnings results on Wednesday, August 6th. The company reported $0.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.71 by $0.10. The business had revenue of $197.34 million for the quarter, compared to analyst estimates of $190.24 million. U.S. Physical Therapy had a net margin of 5.05% and a return on equity of 8.78%. U.S. Physical Therapy’s revenue was up 18.0% compared to the same quarter last year. During the same period last year, the business posted $0.73 EPS. On average, sell-side analysts expect that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 12th. Investors of record on Friday, August 22nd will be given a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend is Friday, August 22nd. U.S. Physical Therapy’s payout ratio is currently 78.60%.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.